Skip to content

Clinical trials

Hepatitis trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatitis Country / region: France Clear all

35 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20041
20063
20071
20081
20094
20111
20123
20132
20141
20171
20181
20191
20211
20225
20232
20241
20253
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed25
Active, not recruiting3
Recruiting3
Terminated2
Not yet recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Gilead Sciences4
Vir Biotechnology, Inc.4
Assistance Publique - Hôpitaux de Paris3
ANRS, Emerging Infectious Diseases2
GlaxoSmithKline2
Human Genome Sciences Inc.2
Novartis Pharmaceuticals2
University Hospital, Montpellier2
AbbVie1
AusperBio Therapeutics Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatitis35
Hepatitis C10
Hepatitis B9
Hepatitis B, Chronic7
Liver Diseases7
Hepatitis, Chronic6
Digestive System Diseases5
Hepatitis C, Chronic5
Fibrosis4
Virus Diseases4

Trials

Showing 26 to 35 of 35. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.